160 related articles for article (PubMed ID: 16136393)
1. [Antiangiogenic therapy].
Arias Barquet L
Arch Soc Esp Oftalmol; 2005 Aug; 80(8):435-6. PubMed ID: 16136393
[No Abstract] [Full Text] [Related]
2. Antiangiogenic therapy in neovascular age-related macular degeneration.
Lin RC; Rosenfeld PJ
Int Ophthalmol Clin; 2007; 47(1):117-37. PubMed ID: 17237677
[No Abstract] [Full Text] [Related]
3. Re: Verteporfin combination regimens in the treatment of neovascular age-related macular degeneration.
Nelson M
Retina; 2010 Feb; 30(2):380; author reply 380-1. PubMed ID: 20142719
[No Abstract] [Full Text] [Related]
4. Correspondence.
Uparkar M; Maiti A; Natarajan S
Retina; 2008 Mar; 28(3):527; author reply 527-8. PubMed ID: 18327151
[No Abstract] [Full Text] [Related]
5. Cytokines in neovascular age-related macular degeneration: fundamentals of targeted combination therapy.
de Oliveira Dias JR; Rodrigues EB; Maia M; Magalhães O; Penha FM; Farah ME
Br J Ophthalmol; 2011 Dec; 95(12):1631-7. PubMed ID: 21546514
[TBL] [Abstract][Full Text] [Related]
6. New treatments for age-related macular degeneration.
Imrie FR; Bailey C
Age Ageing; 2007 Jan; 36(1):8-10. PubMed ID: 17264135
[No Abstract] [Full Text] [Related]
7. Anti-VEGF therapy: riding the wave of change.
Hunyor AP
Clin Exp Ophthalmol; 2008 Jul; 36(5):401-2. PubMed ID: 18925912
[No Abstract] [Full Text] [Related]
8. Changes in aqueous vascular endothelial growth factor and pigment epithelium-derived factor after ranibizumab alone or combined with verteporfin for exudative age-related macular degeneration.
Ahn JK; Moon HJ
Am J Ophthalmol; 2009 Nov; 148(5):718-724.e1. PubMed ID: 19674731
[TBL] [Abstract][Full Text] [Related]
9. Comparing ranibizumab with bevacizumab.
Biswas P; Sengupta S; Choudhary R; Home S; Paul A; Sinha S
Ophthalmology; 2011 Mar; 118(3):600-600.e2. PubMed ID: 21376243
[No Abstract] [Full Text] [Related]
10. Verteporfin combination regimens in the treatment of neovascular age-related macular degeneration.
Shah GK; Sang DN; Hughes MS
Retina; 2009 Feb; 29(2):133-48. PubMed ID: 19202423
[TBL] [Abstract][Full Text] [Related]
11. A cost-effectiveness analysis of three treatments for age-related macular degeneration.
Gower EW; Cassard SD; Bass EB; Schein OD; Bressler NM
Retina; 2010 Feb; 30(2):212-21. PubMed ID: 19940805
[TBL] [Abstract][Full Text] [Related]
12. Cost-effectiveness of ranibizumab compared with photodynamic treatment of neovascular age-related macular degeneration.
Hernandez-Pastor LJ; Ortega A; Garcia-Layana A; Giraldez J
Clin Ther; 2008 Dec; 30(12):2436-51. PubMed ID: 19167602
[TBL] [Abstract][Full Text] [Related]
13. Photodynamic therapy with verteporfin combined with intravitreal injection of bevacizumab for exudative age-related macular degeneration.
Aggio FB; Melo GB; Höfling-Lima AL; Eid Farah M
Acta Ophthalmol Scand; 2006 Dec; 84(6):831-3. PubMed ID: 17083553
[No Abstract] [Full Text] [Related]
14. Ranibizumab and nonocular hemorrhage.
Beaumont PE; Kang HK
Ophthalmology; 2009 Aug; 116(8):1593. PubMed ID: 19651322
[No Abstract] [Full Text] [Related]
15. [Position of the Retinological Society, the German Ophthalmological Society and the Professional Association of Ophthalmologists in Germany on the current therapeutic possibilities for neovascular age-related macular degeneration].
Klin Monbl Augenheilkd; 2007 Jul; 224(7):559-66. PubMed ID: 17657689
[TBL] [Abstract][Full Text] [Related]
16. Necessity of paracentesis before or after intravitreal injection of bevacizumab.
Huang WC; Lin JM; Chiang CC; Tsai YY
Arch Ophthalmol; 2008 Sep; 126(9):1314-5; author reply 1315. PubMed ID: 18779502
[No Abstract] [Full Text] [Related]
17. [Treatment of neovascular age-related macular degeneration with antiangiogenic drugs].
Rodrigues EB; Rossi EE; Grumann Junior A; Meyer CH; Ho AC
Arq Bras Oftalmol; 2006; 69(5):756-65. PubMed ID: 17187150
[TBL] [Abstract][Full Text] [Related]
18. [VEGF inhibitors in ophthalmology].
Thys J; Dupont G; Rakic JM
Rev Med Liege; 2009; 64(5-6):323-6. PubMed ID: 19642468
[TBL] [Abstract][Full Text] [Related]
19. [Introduction to the topic: anti-VEGF therapy in the management of AMD].
Meyer CH
Ophthalmologe; 2008 Feb; 105(2):123-4. PubMed ID: 18256843
[No Abstract] [Full Text] [Related]
20. Ranibizumab for the treatment of neovascular age-related macular degeneration: a review.
Kourlas H; Abrams P
Clin Ther; 2007 Sep; 29(9):1850-61. PubMed ID: 18035187
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
